Summary Notice Of Pendency Of Class Action
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK
No. 04-CV-9866 (LTS)(HBP)
ECF CASE
In re Pfizer Inc. Securities Litigation
To: All persons and entities who purchased and/or otherwise acquired Pfizer Inc. ("Pfizer" or "PFE") common stock between and including October 31, 2000 and October 19, 2005 ("Class Period") (the "Main Class").*
NEW YORK, July 30, 2012 /PRNewswire/ -- YOU ARE HEREBY NOTIFIED, pursuant to Rule 23 of the Federal Rules of Civil Procedure and an Order of the United States District Court for the Southern District of New York, that the above-captioned litigation (the "Action") has been certified as a class action.
IF YOU ARE A MEMBER OF THE CLASS, YOUR RIGHTS WILL BE AFFECTED BY THIS ACTION. A full printed Notice of Pendency of Class Action is currently being mailed to known Class Members. If you have not yet received the full printed Notice, you may obtain copies of this document by contacting the Notice Administrator at: Pfizer Securities Litigation, Notice Administrator, P.O. Box 3410, Portland, OR 97208-3410, (888) 236-0464, www.PfizerSecuritiesLitigation.com.
Inquiries, other than requests for the Notice, may be made to Class Counsel: Jay W. Eisenhofer, Esquire, GRANT & EISENHOFER P.A., 485 Lexington Avenue, 29th Floor, New York, NY 10017, (646) 722-8500 or Mary S. Thomas, Esquire, GRANT & EISENHOFER P.A., 123 Justison Street, Wilmington, DE 19801, (302) 622-7000.
If you are within the Class definition and are not otherwise excluded, you have the right to decide whether to remain a member of the Class. If you choose to remain a member of the Class, you do not need to do anything at this time other than to retain your documentation reflecting your transactions in Pfizer common stock. You will automatically be included in the Class. If you are a Class Member and do not exclude yourself from the Class, you will be bound by the proceedings in this Action, including all past, present and future orders and judgments of the Court, whether favorable or unfavorable.
If you ask to be excluded from the Class, you will not be bound by any order or judgment of this Court, and you will not be eligible to receive a share of any money that might be recovered for the benefit of the Class. To exclude yourself from the Class, you must submit a written request for exclusion postmarked no later than September 9, 2012 in accordance with the instructions set forth in the full printed Notice. Pursuant to Rule 23(e)(4) of the Federal Rules of Civil Procedure, it is within the Court's discretion as to whether a second opportunity to request exclusion from the Class will be allowed if there is a settlement or judgment in the Action. A final Pre-Trial Conference has been scheduled for September 14, 2012. At this time, the Court has not set a date for the trial to begin.
Further information may be obtained by directing your inquiry in writing to the Notice Administrator.
* Excluded from the Main Class are: (a) any persons or entities who both purchased and sold all of their shares of Pfizer common stock between and including October 31, 2000 and October 6, 2004; (b) Pfizer and Individual Defendants Henry A. McKinnell, John L. LaMattina, Karen L. Katen, Joseph M. Feczko and Gail Cawkwell; (c) members of the immediate family of each of the Individual Defendants; (d) subsidiaries or affiliates of Pfizer or any of the Individual Defendants; (e) any person or entity who is, or was during the Class Period, a partner, officer, director, employee or controlling person of Pfizer or any of the Individual Defendants; (f) any entity in which any of the Individual Defendants has a controlling interest; (g) the legal representatives, heirs, successors or assigns of any of the excluded persons or entities specified in this paragraph; and (h) the insurance carriers or their affiliates who insure the Defendants. The Court also certified a sub-class consisting of all members of the Main Class, not otherwise excluded, who purchased Pfizer common stock contemporaneously with sales of Pfizer common stock by Individual Defendants Henry A. McKinnell, Karen L. Katen and John L. LaMattina on any of the following dates: October 26, 2000, November 6, 2000, October 19, 2001, October 23, 2001, February 21, 2002, February 25, 2002, February 27, 2003, November 18, 2003, February 24, 2005, May 6, 2005, May 10, 2005 and/or August 16, 2005 (the "20A Subclass" and together with the Main Class, the "Class").
Dated: July 5, 2012
By Order of The United States District Court Southern District of New York
http://www.PfizerSecuritiesLitigation.com
SOURCE UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article